IDH1 c.395G>T ;(p.R132L)

Variant ID: 2-209113112-C-A

NM_005896.2(IDH1):c.395G>T;(p.R132L)

This variant was identified in 307 publications

View GRCh38 version.




Publications:


The Role of Biomarkers in Guiding Clinical Decision-Making in Oncology.

Journal Of The Advanced Practitioner In Oncology
Moore, Donald C DC; Guinigundo, Andrew S AS
Publication Date: 2023-04

Variant appearance in text: IDH1: R132L
PubMed Link: 37206905
Variant Present in the following documents:
  • Main text
  • jadpro-14-15.pdf
View BVdb publication page



The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer.

Acta Pharmaceutica Sinica. B
Liu, Yang Y; Xu, Wei W; Li, Mingxue M; Yang, Yueying Y; Sun, Dejuan D; Chen, Lidian L; Li, Hua H; Chen, Lixia L
Publication Date: 2023-04

Variant appearance in text: IDH1: R132L
PubMed Link: 37139412
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas.

Molecules (Basel, Switzerland)
Neumaier, Felix F; Zlatopolskiy, Boris D BD; Neumaier, Bernd B
Publication Date: 2023-03-23

Variant appearance in text: IDH1: R132L
PubMed Link: 37049661
Variant Present in the following documents:
  • Main text
  • molecules-28-02890.pdf
View BVdb publication page



Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non-small Cell Lung Cancer.

Cancer Research Communications
Frank, Malene S MS; Andersen, Christina S A CSA; Ahlborn, Lise B LB; Pallisgaard, Niels N; Bodtger, Uffe U; Gehl, Julie J
Publication Date: 2022-10

Variant appearance in text: IDH1: 395G>T; R132L
PubMed Link: 36969747
Variant Present in the following documents:
  • crc-22-0258-s08.xlsx, sheet 1
View BVdb publication page



Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.

Cancer Research Communications
White, Jason A JA; Kaninjing, Ernest T ET; Adeniji, Kayode A KA; Jibrin, Paul P; Obafunwa, John O JO; Ogo, Chidiebere N CN; Mohammed, Faruk F; Popoola, Ademola A; Fatiregun, Omolara A OA; Oluwole, Olabode P OP; Karanam, Balasubramanyam B; Elhussin, Isra I; Ambs, Stefan S; Tang, Wei W; Davis, Melissa M; Polak, Paz P; Campbell, Moray J MJ; Brignole, Kathryn R KR; Rotimi, Solomon O SO; Dean-Colomb, Windy W; Odedina, Folake T FT; Martin, Damali N DN; Yates, Clayton C
Publication Date: 2022-09

Variant appearance in text: N/A
PubMed Link: 36922933
Variant Present in the following documents:
View BVdb publication page



Rational Computational Approaches in Drug Discovery: Potential Inhibitors for Allosteric Regulation of Mutant Isocitrate Dehydrogenase-1 Enzyme in Cancers.

Molecules (Basel, Switzerland)
Thamim, Masthan M; Agrahari, Ashish Kumar AK; Gupta, Pawan P; Thirumoorthy, Krishnan K
Publication Date: 2023-03-02

Variant appearance in text: IDH1: R132L
PubMed Link: 36903561
Variant Present in the following documents:
  • Main text
  • molecules-28-02315.pdf
View BVdb publication page



Accurate prediction of isocitrate dehydrogenase -mutation status of gliomas using SLOW-editing magnetic resonance spectroscopic imaging at 7 T MR.

Neuro-Oncology Advances
Weng, Guodong G; Ermiş, Ekin E; Maragkou, Theoni T; Krcek, Reinhardt R; Reinhardt, Philipp P; Zubak, Irena I; Schucht, Philippe P; Wiest, Roland R; Slotboom, Johannes J; Radojewski, Piotr P
Publication Date: 2023

Variant appearance in text: IDH1: R132L
PubMed Link: 36875625
Variant Present in the following documents:
  • vdad001.pdf
View BVdb publication page



Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer.

Cancer Discovery
Pradat, Yoann Y; Viot, Julien J; Yurchenko, Andrey A AA; Gunbin, Konstantin K; Cerbone, Luigi L; Deloger, Marc M; Grisay, Guillaume G; Verlingue, Loic L; Scott, Veronique V; Padioleau, Ismael I; Panunzi, Leonardo L; Michiels, Stefan S; Hollebecque, Antoine A; Jules-Clement, Gerome G; Mezquita, Laura L; Laine, Antoine A; Loriot, Yohann Y; Besse, Benjamin B; Friboulet, Luc L; Andre, Fabrice F; Cournede, Paul-Henry PH; Gautheret, Daniel D; Nikolaev, Sergey I SI
Publication Date: 2023-03-02

Variant appearance in text: IDH1: 395G>T; R132L; rs121913500
PubMed Link: 36862804
Variant Present in the following documents:
  • cd-22-0966_supplementary_tables_s1-s11_suppst1.xlsx, sheet 6
View BVdb publication page



Network expansion of genetic associations defines a pleiotropy map of human cell biology.

Nature Genetics
Barrio-Hernandez, Inigo I; Schwartzentruber, Jeremy J; Shrivastava, Anjali A; Del-Toro, Noemi N; Gonzalez, Asier A; Zhang, Qian Q; Mountjoy, Edward E; Suveges, Daniel D; Ochoa, David D; Ghoussaini, Maya M; Bradley, Glyn G; Hermjakob, Henning H; Orchard, Sandra S; Dunham, Ian I; Anderson, Carl A CA; Porras, Pablo P; Beltrao, Pedro P
Publication Date: 2023-02-23

Variant appearance in text: IDH1: 395G>T; Arg132Leu
PubMed Link: 36823319
Variant Present in the following documents:
  • 41588_2023_1327_MOESM4_ESM.xlsx, sheet 6
View BVdb publication page



Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.

Nature Communications
Hong, Lingzhi L; Aminu, Muhammad M; Li, Shenduo S; Lu, Xuetao X; Petranovic, Milena M; Saad, Maliazurina B MB; Chen, Pingjun P; Qin, Kang K; Varghese, Susan S; Rinsurongkawong, Waree W; Rinsurongkawong, Vadeerat V; Spelman, Amy A; Elamin, Yasir Y YY; Negrao, Marcelo V MV; Skoulidis, Ferdinandos F; Gay, Carl M CM; Cascone, Tina T; Gandhi, Saumil J SJ; Lin, Steven H SH; Lee, Percy P PP; Carter, Brett W BW; Wu, Carol C CC; Antonoff, Mara B MB; Sepesi, Boris B; Lewis, Jeff J; Gibbons, Don L DL; Vaporciyan, Ara A AA; Le, Xiuning X; Jack Lee, J J; Roy-Chowdhuri, Sinchita S; Routbort, Mark J MJ; Gainor, Justin F JF; Heymach, John V JV; Lou, Yanyan Y; Wu, Jia J; Zhang, Jianjun J; Vokes, Natalie I NI
Publication Date: 2023-02-08

Variant appearance in text: IDH1: R132L
PubMed Link: 36755027
Variant Present in the following documents:
  • 41467_2023_36328_MOESM6_ESM.xlsx, sheet 1
  • 41467_2023_36328_MOESM8_ESM.xlsx, sheet 1
View BVdb publication page



Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for IDH1/2 Mutation in Adult AML.

Cancers
Kao, Hsiao-Wen HW; Kuo, Ming-Chung MC; Huang, Ying-Jung YJ; Chang, Hung H; Hu, Shu-Fen SF; Huang, Chein-Fuang CF; Hung, Yu-Shin YS; Lin, Tung-Liang TL; Ou, Che-Wei CW; Lien, Ming-Yu MY; Wu, Jin-Hou JH; Chen, Chih-Cheng CC; Shih, Lee-Yung LY
Publication Date: 2022-12-15

Variant appearance in text: IDH1: R132L
PubMed Link: 36551690
Variant Present in the following documents:
  • Main text
  • cancers-14-06205.pdf
View BVdb publication page



Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Cheng, Wen-Yan WY; Li, Jian-Feng JF; Zhu, Yong-Mei YM; Lin, Xiang-Jie XJ; Wen, Li-Jun LJ; Zhang, Fan F; Zhang, Yu-Liang YL; Zhao, Ming M; Fang, Hai H; Wang, Sheng-Yue SY; Lin, Xiao-Jing XJ; Qiao, Niu N; Yin, Wei W; Zhang, Jia-Nan JN; Dai, Yu-Ting YT; Jiang, Lu L; Sun, Xiao-Jian XJ; Xu, Yi Y; Zhang, Tong-Tong TT; Chen, Su-Ning SN; Zhu, Hong-Hu HH; Chen, Zhu Z; Jin, Jie J; Wu, De-Pei DP; Shen, Yang Y; Chen, Sai-Juan SJ
Publication Date: 2022-12-06

Variant appearance in text: IDH1: 395G>T; Arg132Leu
PubMed Link: 36442087
Variant Present in the following documents:
  • pnas.2211429119.sd02.xlsx, sheet 1
View BVdb publication page



A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study.

The Lancet. Haematology
,
Publication Date: 2022-11-24

Variant appearance in text: IDH1: 395G>T; R132L
PubMed Link: 36436542
Variant Present in the following documents:
  • mmc2.xlsx, sheet 1
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: IDH1: R132L
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Human metastatic cholangiocarcinoma patient-derived xenografts and tumoroids for preclinical drug evaluation.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Serra-Camprubí, Queralt Q; Verdaguer, Helena H; Oliveros, Winona W; Lupión-Garcia, Núria N; Llop-Guevara, Alba A; Molina, Cristina C; Vila-Casadesús, Maria M; Turpin, Anthony A; Neuzillet, Cindy C; Frigola, Joan J; Querol, Jessica J; Yáñez-Bartolomé, Mariana M; Castet, Florian F; Fabregat-Franco, Carles C; Escudero-Iriarte, Carmen C; Escorihuela, Marta M; Arenas, Enrique J EJ; Bernado-Morales, Cristina C; Haro, Noemí N; Giles, Francis J FJ; Pozo, Oscar J OJ; Miquel, Josep M JM; Nuciforo, Paolo G PG; Vivancos, Ana A; Melé, Marta M; Serra, Violeta V; Arribas, Joaquín J; Tabernero, Josep J; Peiró, Sandra S; Macarulla, Teresa T; Tian, Tian V TV
Publication Date: 2022-11-14

Variant appearance in text: IDH1: 395G>T; R132L
PubMed Link: 36374558
Variant Present in the following documents:
  • Main text
  • ccr-22-2551_supplementary_table_s4_suppts4.xlsx, sheet 8
  • 432.pdf
View BVdb publication page



Newest Therapies for Cholangiocarcinoma: An Updated Overview of Approved Treatments with Transplant Oncology Vision.

Cancers
Zhang, Yuqi Y; Esmail, Abdullah A; Mazzaferro, Vincenzo V; Abdelrahim, Maen M
Publication Date: 2022-10-17

Variant appearance in text: IDH1: R132L
PubMed Link: 36291857
Variant Present in the following documents:
  • cancers-14-05074.pdf
View BVdb publication page



Implications of Concurrent IDH1 and IDH2 Mutations on Survival in Glioma-A Case Report and Systematic Review.

Current Issues In Molecular Biology
Yuile, Alexander A; Satgunaseelan, Laveniya L; Wei, Joe J; Kastelan, Marina M; Back, Michael F MF; Lee, Maggie M; Wei, Heng H; Buckland, Michael E ME; Lee, Adrian A; Wheeler, Helen R HR
Publication Date: 2022-10-21

Variant appearance in text: IDH1: R132L
PubMed Link: 36286062
Variant Present in the following documents:
  • Main text
  • cimb-44-00348.pdf
View BVdb publication page



Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology
Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W
Publication Date: 2022

Variant appearance in text: IDH1: 395G>T; R132L
PubMed Link: 36238300
Variant Present in the following documents:
  • Table_1.xlsx, sheet 4
View BVdb publication page



The mutational landscape of cancer's vulnerability to ionizing radiation.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Gopal, Priyanka P; Yard, Brian D BD; Petty, Aaron A; Lal, Jessica C JC; Bera, Titas K TK; Hoang, Trung Q TQ; Buhimschi, Alexandru B AB; Abazeed, Mohamed E ME
Publication Date: 2022-10-12

Variant appearance in text: IDH1: R132L
PubMed Link: 36222846
Variant Present in the following documents:
  • ccr-22-1914_supplementary_data_2_suppds2.xlsx, sheet 1
  • ccr-22-1914_supplementary_data_3_suppds3.xlsx, sheet 1
View BVdb publication page



Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma.

Asian Pacific Journal Of Cancer Prevention : Apjcp
Sabunga, Olivia Desty OD; Kaelan, Cahyono C; Zainuddin, Andi Alfian AA; Sungowati, Ni Ketut NK; Cangara, Muhammad Husni MH; Miskad, Upik U
Publication Date: 2022-09-01

Variant appearance in text: IDH1: R132L
PubMed Link: 36172668
Variant Present in the following documents:
  • Main text
  • APJCP-23-3051.pdf
View BVdb publication page



EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine
Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W
Publication Date: 2022-09-19

Variant appearance in text: IDH1: 395G>T; R132L
PubMed Link: 36123678
Variant Present in the following documents:
  • 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer.

Frontiers In Oncology
Yu, Haipeng H; Xu, Yan Y; Gao, Wei W; Li, Mei M; He, Ji'an J; Deng, Xiaoqian X; Xing, Wenge W
Publication Date: 2022

Variant appearance in text: IDH1: R132L
PubMed Link: 36072793
Variant Present in the following documents:
  • Table_3.xlsx, sheet 1
View BVdb publication page



Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detection.

Molecular Oncology
Favre, Loetitia L; Sako, Nouhoum N; Tarfi, Sihem S; Quang, Violaine Tran VT; Joy, Corine C; Dupuy, Aurélie A; Guillerm, Erell E; Gaulard, Philippe P; Wagner-Ballon, Orianne O; Pujals, Anaïs A; Sloma, Ivan I
Publication Date: 2022-12

Variant appearance in text: IDH1: R132L
PubMed Link: 36062346
Variant Present in the following documents:
  • Main text
View BVdb publication page



SNPMap-An integrated visual SNP interpretation tool.

Frontiers In Genetics
Liu, Miaosen M; Yang, Jian J; Duan, Huilong H; Yu, Lan L; Wu, Dingwen D; Li, Haomin H
Publication Date: 2022

Variant appearance in text: rs121913500
PubMed Link: 36061173
Variant Present in the following documents:
  • Main text
  • fgene-13-985500.pdf
View BVdb publication page



Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics.

Molecular Diagnosis & Therapy
Śledzińska, Paulina P; Bebyn, Marek M; Szczerba, Ewelina E; Furtak, Jacek J; Harat, Maciej M; Olszewska, Natalia N; Kamińska, Katarzyna K; Kowalewski, Janusz J; Lewandowska, Marzena A MA
Publication Date: 2022-11

Variant appearance in text: IDH1: 395G>T; R132L
PubMed Link: 36053463
Variant Present in the following documents:
  • Main text
  • 40291_2022_Article_612.pdf
View BVdb publication page



A genetic model for central chondrosarcoma evolution correlates with patient outcome.

Genome Medicine
Cross, William W; Lyskjær, Iben I; Lesluyes, Tom T; Hargreaves, Steven S; Strobl, Anna-Christina AC; Davies, Christopher C; Waise, Sara S; Hames-Fathi, Shadi S; Oukrif, Dahmane D; Ye, Hongtao H; Amary, Fernanda F; Tirabosco, Roberto R; Gerrand, Craig C; Baker, Toby T; Barnes, David D; Steele, Christopher C; Alexandrov, Ludmil L; Bond, Gareth G; , ; Cool, Paul P; Pillay, Nischalan N; Van Loo, Peter P; Flanagan, Adrienne M AM
Publication Date: 2022-08-30

Variant appearance in text: IDH1: R132L
PubMed Link: 36042521
Variant Present in the following documents:
  • 13073_2022_1084_MOESM1_ESM.xls, sheet 2
  • 13073_2022_1084_MOESM1_ESM.xls, sheet 3
View BVdb publication page



Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.

Leukemia
Jahn, Nikolaus N; Jahn, Ekaterina E; Saadati, Maral M; Bullinger, Lars L; Larson, Richard A RA; Ottone, Tiziana T; Amadori, Sergio S; Prior, Thomas W TW; Brandwein, Joseph M JM; Appelbaum, Frederick R FR; Medeiros, Bruno C BC; Tallman, Martin S MS; Ehninger, Gerhard G; Heuser, Michael M; Ganser, Arnold A; Pallaud, Celine C; Gathmann, Insa I; Krzykalla, Julia J; Benner, Axel A; Bloomfield, Clara D CD; Thiede, Christian C; Stone, Richard M RM; Döhner, Hartmut H; Döhner, Konstanze K
Publication Date: 2022-09

Variant appearance in text: IDH1: R132L
PubMed Link: 35922444
Variant Present in the following documents:
  • 41375_2022_1650_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Role of PARP Inhibitors in Glioblastoma and Perceiving Challenges as Well as Strategies for Successful Clinical Development.

Frontiers In Pharmacology
Bisht, Priya P; Kumar, V Udaya VU; Pandey, Ruchi R; Velayutham, Ravichandiran R; Kumar, Nitesh N
Publication Date: 2022

Variant appearance in text: IDH1: R132L
PubMed Link: 35873570
Variant Present in the following documents:
  • Main text
  • fphar-13-939570.pdf
View BVdb publication page



Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.

Nature Genetics
Kar, Siddhartha P SP; Quiros, Pedro M PM; Gu, Muxin M; Jiang, Tao T; Mitchell, Jonathan J; Langdon, Ryan R; Iyer, Vivek V; Barcena, Clea C; Vijayabaskar, M S MS; Fabre, Margarete A MA; Carter, Paul P; Petrovski, Slavé S; Burgess, Stephen S; Vassiliou, George S GS
Publication Date: 2022-08

Variant appearance in text: IDH1: R132L
PubMed Link: 35835912
Variant Present in the following documents:
  • 41588_2022_1121_MOESM3_ESM.xlsx, sheet 2
View BVdb publication page



Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study.

Frontiers In Oncology
Shen, Fangfang F; Liang, Naixin N; Fan, Zaiwen Z; Zhao, Min M; Kang, Jing J; Wang, Xifang X; Hu, Qun Q; Mu, Yongping Y; Wang, Kai K; Yuan, Mingming M; Chen, Rongrong R; Guo, Wei W; Dong, Guilan G; Zhao, Jun J; Bai, Jun J
Publication Date: 2022

Variant appearance in text: IDH1: 395G>T; R132L
PubMed Link: 35814426
Variant Present in the following documents:
  • DataSheet_1.xlsx, sheet 2
View BVdb publication page



The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.

Nature Communications
Vo, Josh N JN; Wu, Yi-Mi YM; Mishler, Jeanmarie J; Hall, Sarah S; Mannan, Rahul R; Wang, Lisha L; Ning, Yu Y; Zhou, Jin J; Hopkins, Alexander C AC; Estill, James C JC; Chan, Wallace K B WKB; Yesil, Jennifer J; Cao, Xuhong X; Rao, Arvind A; Tsodikov, Alexander A; Talpaz, Moshe M; Cole, Craig E CE; Ye, Jing C JC; , ; Bergsagel, P Leif PL; Auclair, Daniel D; Cho, Hearn Jay HJ; Robinson, Dan R DR; Chinnaiyan, Arul M AM
Publication Date: 2022-06-29

Variant appearance in text: IDH1: 395G>T; Arg132Leu
PubMed Link: 35768438
Variant Present in the following documents:
  • 41467_2022_31430_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Maffucci syndrome complicated by giant chondrosarcoma in the left ankle with an IDH1 R132C mutation: a case report.

World Journal Of Surgical Oncology
Lv, Haiyan H; Jiang, Hantao H; Zhang, Minge M; Luo, Huarong H; Hong, Zhenghua Z; Yang, Hai H; Xu, Weiming W; Shen, Bo B; Zhang, Wei W; Qiu, Hao H; Zhu, Rangteng R
Publication Date: 2022-06-29

Variant appearance in text: IDH1: 395G>T; Arg132Leu
PubMed Link: 35765075
Variant Present in the following documents:
  • Main text
  • 12957_2022_Article_2686.pdf
View BVdb publication page



The first-in-human phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas.

Neuro-Oncology
Natsume, Atsushi A; Arakawa, Yoshiki Y; Narita, Yoshitaka Y; Sugiyama, Kazuhiko K; Hata, Nobuhiro N; Muragaki, Yoshihiro Y; Shinojima, Naoki N; Kumabe, Toshihiro T; Saito, Ryuta R; Motomura, Kazuya K; Mineharu, Yohei Y; Miyakita, Yasuji Y; Yamasaki, Fumiyuki F; Matsushita, Yuko Y; Ichimura, Koichi K; Ito, Kazumi K; Tachibana, Masaya M; Kakurai, Yasuyuki Y; Okamoto, Naoko N; Asahi, Takashi T; Nishijima, Soichiro S; Yamaguchi, Tomoyuki T; Tsubouchi, Hiroshi H; Nakamura, Hideo H; Nishikawa, Ryo R
Publication Date: 2022-06-20

Variant appearance in text: IDH1: R132L
PubMed Link: 35722822
Variant Present in the following documents:
  • Main text
  • noac155.pdf
View BVdb publication page



Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.

Nature Communications
Gounder, Mrinal M MM; Agaram, Narasimhan P NP; Trabucco, Sally E SE; Robinson, Victoria V; Ferraro, Richard A RA; Millis, Sherri Z SZ; Krishnan, Anita A; Lee, Jessica J; Attia, Steven S; Abida, Wassim W; Drilon, Alexander A; Chi, Ping P; Angelo, Sandra P D' SP; Dickson, Mark A MA; Keohan, Mary Lou ML; Kelly, Ciara M CM; Agulnik, Mark M; Chawla, Sant P SP; Choy, Edwin E; Chugh, Rashmi R; Meyer, Christian F CF; Myer, Parvathi A PA; Moore, Jessica L JL; Okimoto, Ross A RA; Pollock, Raphael E RE; Ravi, Vinod V; Singh, Arun S AS; Somaiah, Neeta N; Wagner, Andrew J AJ; Healey, John H JH; Frampton, Garrett M GM; Venstrom, Jeffrey M JM; Ross, Jeffrey S JS; Ladanyi, Marc M; Singer, Samuel S; Brennan, Murray F MF; Schwartz, Gary K GK; Lazar, Alexander J AJ; Thomas, David M DM; Maki, Robert G RG; Tap, William D WD; Ali, Siraj M SM; Jin, Dexter X DX
Publication Date: 2022-06-15

Variant appearance in text: IDH1: R132L
PubMed Link: 35705558
Variant Present in the following documents:
  • 41467_2022_30496_MOESM2_ESM.xls, sheet 1
View BVdb publication page



The longitudinal dynamics and natural history of clonal haematopoiesis.

Nature
Fabre, Margarete A MA; de Almeida, José Guilherme JG; Fiorillo, Edoardo E; Mitchell, Emily E; Damaskou, Aristi A; Rak, Justyna J; Orrù, Valeria V; Marongiu, Michele M; Chapman, Michael Spencer MS; Vijayabaskar, M S MS; Baxter, Joanna J; Hardy, Claire C; Abascal, Federico F; Williams, Nicholas N; Nangalia, Jyoti J; Martincorena, Iñigo I; Campbell, Peter J PJ; McKinney, Eoin F EF; Cucca, Francesco F; Gerstung, Moritz M; Vassiliou, George S GS
Publication Date: 2022-06

Variant appearance in text: IDH1: R132L
PubMed Link: 35650444
Variant Present in the following documents:
  • 41586_2022_4785_MOESM13_ESM.xlsx, sheet 3
  • 41586_2022_4785_MOESM12_ESM.xlsx, sheet 1
View BVdb publication page



Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: a multicenter, open-label, phase 1b/2 trial.

Neuro-Oncology
de la Fuente, Macarena I MI; Colman, Howard H; Rosenthal, Mark M; Van Tine, Brian A BA; Levacic, Danijela D; Walbert, Tobias T; Gan, Hui K HK; Vieito, Maria M; Milhem, Mohammed M MM; Lipford, Kathryn K; Forsyth, Sanjeev S; Guichard, Sylvie M SM; Mikhailov, Yelena Y; Sedkov, Alexander A; Brevard, Julie J; Kelly, Patrick F PF; Mohamed, Hesham H; Monga, Varun V
Publication Date: 2022-05-25

Variant appearance in text: IDH1: R132L
PubMed Link: 35639513
Variant Present in the following documents:
  • Main text
  • noac139.pdf
View BVdb publication page



Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q.

Ebiomedicine
Adema, Vera V; Palomo, Laura L; Walter, Wencke W; Mallo, Mar M; Hutter, Stephan S; La Framboise, Thomas T; Arenillas, Leonor L; Meggendorfer, Manja M; Radivoyevitch, Tomas T; Xicoy, Blanca B; Pellagatti, Andrea A; Haferlach, Claudia C; Boultwood, Jacqueline J; Kern, Wolfgang W; Visconte, Valeria V; Sekeres, Mikkael M; Barnard, John J; Haferlach, Torsten T; Solé, Francesc F; Maciejewski, Jaroslaw P JP
Publication Date: 2022-06

Variant appearance in text: IDH1: 395G>T; Arg132Leu
PubMed Link: 35617825
Variant Present in the following documents:
  • mmc3.xlsx, sheet 1
View BVdb publication page



Author Correction: Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.

Nature Communications
Farshidfar, Farshad F; Rhrissorrakrai, Kahn K; Levovitz, Chaya C; Peng, Cong C; Knight, James J; Bacchiocchi, Antonella A; Su, Juan J; Yin, Mingzhu M; Sznol, Mario M; Ariyan, Stephan S; Clune, James J; Olino, Kelly K; Parida, Laxmi L; Nikolaus, Joerg J; Zhang, Meiling M; Zhao, Shuang S; Wang, Yan Y; Huang, Gang G; Wan, Miaojian M; Li, Xianan X; Cao, Jian J; Yan, Qin Q; Chen, Xiang X; Newman, Aaron M AM; Halaban, Ruth R
Publication Date: 2022-05-10

Variant appearance in text: IDH1: R132L
PubMed Link: 35538087
Variant Present in the following documents:
  • 41467_2022_30446_MOESM1_ESM.xlsx, sheet 3
View BVdb publication page



Molecular and clinical characteristics of IDH mutations in Chinese NSCLC patients and potential treatment strategies.

Cancer Medicine
Chen, Shuchen S; Zhu, Honglin H; Jin, Meizi M; Yuan, Hongling H; Liu, Zhenzhen Z; Li, Jielin J; Zhang, Xiang X; Meng, Lihui L; Li, Ting T; Diao, Yuzhu Y; Gao, Hong H; Hong, Chengyu C; Zhu, Xinjiang X; Zheng, Jian J; Li, Fei F; Niu, Yanling Y; Ma, Tonghui T; Li, Xiaoling X
Publication Date: 2022-11

Variant appearance in text: IDH1: R132L
PubMed Link: 35526267
Variant Present in the following documents:
  • Main text
  • CAM4-11-4122.pdf
View BVdb publication page



RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS.

Leukemia
Kaisrlikova, Monika M; Vesela, Jitka J; Kundrat, David D; Votavova, Hana H; Dostalova Merkerova, Michaela M; Krejcik, Zdenek Z; Divoky, Vladimir V; Jedlicka, Marek M; Fric, Jan J; Klema, Jiri J; Mikulenkova, Dana D; Stastna Markova, Marketa M; Lauermannova, Marie M; Mertova, Jolana J; Soukupova Maaloufova, Jacqueline J; Jonasova, Anna A; Cermak, Jaroslav J; Belickova, Monika M
Publication Date: 2022-07

Variant appearance in text: IDH1: 395G>T; Arg132Leu
PubMed Link: 35505182
Variant Present in the following documents:
  • 41375_2022_1584_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma.

Journal Of Bone Oncology
Nakagawa, Makoto M; Yamaguchi, Masayuki M; Endo, Makoto M; Machida, Yukino Y; Hattori, Ayuna A; Tanzawa, Fumie F; Tsutsumi, Shinji S; Kitabayashi, Issay I; Kawai, Akira A; Nakatani, Fumihiko F
Publication Date: 2022-06

Variant appearance in text: IDH1: R132L
PubMed Link: 35493690
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows.

Bmc Medical Genomics
Sobahy, Turki M TM; Tashkandi, Ghassan G; Bahussain, Donya D; Al-Harbi, Raneem R
Publication Date: 2022-04-25

Variant appearance in text: IDH1: 395G>T
PubMed Link: 35468810
Variant Present in the following documents:
  • 12920_2022_1235_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization.

International Journal Of Molecular Sciences
Ebenezer, Oluwakemi O; Shapi, Michael M; Tuszynski, Jack A JA
Publication Date: 2022-04-04

Variant appearance in text: IDH1: R132L
PubMed Link: 35409361
Variant Present in the following documents:
  • Main text
  • ijms-23-04001.pdf
View BVdb publication page



Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.

Cancer Medicine
Liu, Binliang B; Yi, Zongbi Z; Guan, Yanfang Y; Ouyang, Quchang Q; Li, Chunxiao C; Guan, Xiuwen X; Lv, Dan D; Li, Lixi L; Zhai, Jingtong J; Qian, Haili H; Xu, Binghe B; Ma, Fei F; Zeng, Yixin Y
Publication Date: 2022-07

Variant appearance in text: IDH1: 395G>T; R132L
PubMed Link: 35393784
Variant Present in the following documents:
  • CAM4-11-2767-s001.xlsx, sheet 1
View BVdb publication page



Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation.

Blood Advances
Bill, Marius M; Jentzsch, Madlen M; Bischof, Lara L; Kohlschmidt, Jessica J; Grimm, Juliane J; Schmalbrock, Laura Katharina LK; Backhaus, Donata D; Brauer, Dominic D; Goldmann, Karoline K; Franke, Georg-Nikolaus GN; Vucinic, Vladan V; Niederwieser, Dietger D; Mims, Alice S AS; Platzbecker, Uwe U; Eisfeld, Ann-Kathrin AK; Schwind, Sebastian S
Publication Date: 2022-04-05

Variant appearance in text: IDH1: 395G>T; R132L
PubMed Link: 35381077
Variant Present in the following documents:
  • BLOODA_ADV-2021-005789-mmc1.pdf
View BVdb publication page



Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas.

Acta Neuropathologica Communications
Wolter, Marietta M; Felsberg, Jörg J; Malzkorn, Bastian B; Kaulich, Kerstin K; Reifenberger, Guido G
Publication Date: 2022-03-31

Variant appearance in text: IDH1: R132L
PubMed Link: 35361262
Variant Present in the following documents:
  • 40478_2022_1335_MOESM1_ESM.pdf
View BVdb publication page